INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Oct 31, 2006 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,000 | -- | -- |
| Oct 31, 2006 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,000 | -- | -- |
| Oct 31, 2006 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,750 | -- | 45,713 |
| Oct 31, 2006 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | -- | 17,308 |
| Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 660
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,311 | $10.56 | 22,198 |
| Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 660
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 24,226 | $10.56 | 33,873 |
| Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 660
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,100 | $10.56 | 12,747 |
| Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 660
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 900 | $10.56 | 10,547 |
| Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 660
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 115 | $10.56 | 9,762 |
| Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 660
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 100 | $10.56 | 9,747 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.